This topic contains a solution. Click here to go to the answer

Author Question: If an IRB thinks that subjects might be at risk in a study, the researcher must be able to convince ... (Read 99 times)

Brittanyd9008

  • Hero Member
  • *****
  • Posts: 500
If an IRB thinks that subjects might be at risk in a study, the researcher must be able to convince the Board that
 
  a. the value of the knowledge to be gained in the study exceeds the potential harm to subjects.
  b. appropriate medical or support services will be available to subjects who feel a need.
  c. subjects will be informed of the risks and the researcher will obtain voluntary and written consent.
  d. a and c
  e. a, b, and c

Question 2

Aubry, a sixthgrade student, remarks, Analyzing fictional literature is too hard. I just can't do it.. According to social cognitive theory, Aubry likely has low feelings of on tasks such as this.
 
  a. self-esteem
  b. self-description
  c. self-efficacy
  d. self-concept



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

diana chang

  • Sr. Member
  • ****
  • Posts: 288
Answer to Question 1

E

Answer to Question 2

c




Brittanyd9008

  • Member
  • Posts: 500
Reply 2 on: Jun 20, 2018
Wow, this really help


Chelseyj.hasty

  • Member
  • Posts: 319
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

Though the United States has largely rejected the metric system, it is used for currency, as in 100 pennies = 1 dollar. Previously, the British currency system was used, with measurements such as 12 pence to the shilling, and 20 shillings to the pound.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library